Table 1.
No. | (%) | |
Age (years) | ||
Median (range) | 51 | (27–75%) |
Histology | ||
Infiltrating ductal carcinoma | 11 | (92%) |
Infiltrating lobular carcinoma | 0 | (0%) |
Other | 1 | (8%) |
Estrogen receptor status | ||
Positive | 10 | (83%) |
Negative | 2 | (17%) |
HER2 status | ||
Amplified | 1 | (8%) |
Normal | 11 | (92%) |
Tumor size (pT) | ||
pT1 | 7 | (58%) |
pT2–pT4 | 5 | (42%) |
Nodal status | ||
Positive | 5 | (42%) |
Negative | 7 | (58%) |
Neoadjuvant chemotherapy | ||
Yes | 5 | (42%) |
No | 7 | (58%) |